EXCLUSIVE: The U.K. drugmaker currently has five approved cancer medicines and a clinical-stage portfolio of about 15 assets.
GSK Sees Cancer-Drug Pipeline Nearly Doubling Next Year After Dealmaking Spree
Source: WSJ Technology
The Edge of the Cyber World See the latest
EXCLUSIVE: The U.K. drugmaker currently has five approved cancer medicines and a clinical-stage portfolio of about 15 assets.
Source: WSJ Technology